Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in DMRA — Damora Therapeutics, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to DMRA Full portfolio

Position in DMRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,451,403
+$5,403,621 QoQ
Shares Held
324,929
+176.1% QoQ
Ownership
0.526%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 104 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in DMRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. DMRA ranks #72 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in DMRA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,451,403 324,929
2026-03-31 $3,047,782 117,675